Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2012041512) COLLAGENASE G AND COLLAGENASE H COMPOSITIONS FOR THE TREATMENT OF DISEASES INVOLVING ALTERATIONS OF COLLAGEN
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2012/041512 International Application No.: PCT/EP2011/004890
Publication Date: 05.04.2012 International Filing Date: 30.09.2011
Chapter 2 Demand Filed: 25.07.2012
IPC:
A61K 38/48 (2006.01) ,A61K 47/36 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43
Enzymes; Proenzymes; Derivatives thereof
46
Hydrolases (3)
48
acting on peptide bonds (3.4)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
30
Macromolecular compounds
36
Polysaccharides; Derivatives thereof
Applicants:
PROTEOS BIOTECH S.L.U. [ES/ES]; c/ Almansa, 14 E-02006 Albacete, ES (AllExceptUS)
MUNOZ MONTANO, Juan Ramon [ES/ES]; ES (UsOnly)
Inventors:
MUNOZ MONTANO, Juan Ramon; ES
Agent:
LORENTE BERGES, Ana; C/ Félix Boix 3, 7 centro E-28036 Madrid, ES
Priority Data:
P20100125530.09.2010ES
Title (EN) COLLAGENASE G AND COLLAGENASE H COMPOSITIONS FOR THE TREATMENT OF DISEASES INVOLVING ALTERATIONS OF COLLAGEN
(FR) COMPOSITIONS DE COLLAGÉNASE G ET DE COLLAGÉNASE H POUR LE TRAITEMENT DE MALADIES IMPLIQUANT DES ALTÉRATIONS DU COLLAGÈNE
Abstract:
(EN) Compositions comprising collagenase G and collagenase H (in a ratio between 1 : 2,5 and 1 : 3,5), optionally formulated in hydrogels, and its uses as medicament for the treatment of diseases involving alterations of collagen, such as fibromatosis, palmar Dupuytren's contracture, La Peyronie's disease, Ledderhose's disease or retractable scars.
(FR) L'invention concerne des compositions comprenant de la collagénase G et de la collagénase H (dans un rapport compris entre 1:2,5 et 1:3,5), facultativement formulées sous forme d'hydrogels, et leurs utilisations en tant que médicament pour le traitement de maladies impliquant des altérations du collagène, comme la fibromatose, la contracture palmaire de Dupuytren, la maladie de La Peyronie, la maladie de Ledderhose ou les cicatrices rétractiles.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP2621520PT2621520ES2529349US09211316DK2621520